The team at IRLAB is dedicated to address the unmet medical need for treatments of life-altering disorders of the central nervous system. Focus is on developing novel treatments for Parkinson’s disease.
ISP provides competitive advantage
A cornerstone in the work is our unique and proprietary research platform ISP that gives a competitive advantage when identifying the drug candidate with the highest potential of withstanding the thorough testing of clinical trials. The brain is one of the most complex organs in the body and a full understanding of its functionality and causes of diseases has not yet been achieved.
Despite the unknowns, or perhaps because of them, IRLAB’s research team are committed to discover more.
Through the ISP platform, IRLAB is using an advanced systems biology strategy to analyze the complex interactions in the brain. Together, the teams at IRLAB are taking great strides toward the ultimate goal of improving the quality of life for patients with CNS disorders.